New Insights on the Pharmacokinetics of Ulifloxacin After Administration of Prulifloxacin in Patients with Mild, Moderate and Severe Renal Impairment-Reference-Cited by-同舟云学术

New Insights on the Pharmacokinetics of Ulifloxacin After Administration of Prulifloxacin in Patients with Mild, Moderate and Severe Renal Impairment

Published:2018-08-27 Issue:3 Volume:18 Page:237-245
ISSN:1174-5886
Container-title:Drugs in R&D
language:en
Short-container-title:Drugs R D

Author:

Tellone Valeria^ORCID,Coppola Paola,Ammendola Marco,Di Loreto Giorgio,Picollo Rossella,Del Vecchio Alessandra,Comandini Alessandro,Garofolo Fabio,Tongiani Serena

Funder

Angelini S.p.A.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology

Link

http://link.springer.com/article/10.1007/s40268-018-0245-9/fulltext.html

Reference13 articles.

1. Segawa J, Kitano M, Kazuno K, et al. Studies on pyridonecarboxylic acids. 1. Synthesis and antibacterial evaluation of 7-substituted-6-halo-4-oxo-4H-[1,3]thiazeto[3,2-a]quinoline-3- carboxylic acids. J Med Chem. 1992;35:4727–38.

2. Blasi F, Schaberg T, Centanni S, Del Vecchio A, Rosignoli MT, Dionisio P. Prulifloxacin versus levofloxacin in the treatment of severe COPD patients with acute exacerbations of chronic bronchitis. Pulm Pharmacol Ther. 2013;26:609–16.

3. Passali D, Crisanti A, Bellussi LM. Role of prulifloxacin in the treatment of acute rhinosinusitis. Infez Med. 2015;23:301–6.

4. Keam SJ, Perry CM. Prulifloxacin. Drugs. 2004;64:2221–34.

5. Tougou K, Nakamura A, Watanabe S, Okuyama Y, Morino A. Paraoxonase has a major role in the hydrolysis of prulifloxacin (NM441), a prodrug of a new antibacterial agent. Drug Metab Dispos. 1998;26:355–9.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Does dose reduction of renally cleared antibiotics in patients with impaired renal function lead to adequate drug exposure? A systematic review;Clinical Microbiology and Infection;2021-03

2. Quinolones;Reference Module in Biomedical Sciences;2021